People: Discover Financial Services (DFS.N)

DFS.N on New York Stock Exchange

58.39USD
24 Apr 2015
Change (% chg)

$-0.28 (-0.48%)
Prev Close
$58.67
Open
$58.26
Day's High
$58.60
Day's Low
$58.18
Volume
847,818
Avg. Vol
911,273
52-wk High
$66.75
52-wk Low
$54.02

Search Stocks

Aronin, Jeffrey 

Mr. Jeffrey S. Aronin is Independent Director of Discover Financial Services, since 2007. Mr. Aronin is chairman and chief executive officer of Paragon Pharmaceuticals, a global development and biopharmaceutical investment firm, and is chairman and chief executive officer of Marathon Pharmaceuticals, a prescription pharmaceutical company. From 2000 to 2009, Mr. Aronin was president and chief executive officer of Ovation Pharmaceuticals Inc., a biopharmaceutical company he founded in 2000. In 2009, Ovation Pharmaceuticals was acquired by Lundbeck, Inc. Mr. Aronin served as president and chief executive officer of Lundbeck, Inc. in 2009 during its acquisition and integration of Ovation Pharmaceuticals. He is the former chairman and chief executive officer at MedCare Technologies Inc., a publicly held healthcare company.Mr. Aronin has experience as a chief executive officer leading a global pharmaceutical company. His skills include knowledge of strategy and business development, finance and marketing. He brings valuable leadership experience and knowledge in the operations and day-to-day management of a global corporation. Mr. Aronin also has experience in the structuring and execution of strategic corporate transactions, including mergers and acquisitions.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

David Nelms

8,671,740

Roger Hochschild

5,350,920

R. Mark Graf

3,258,650

R. Douglas Rose

--

Kathryn Corley

--

Carlos Minetti

4,970,770
As Of  30 Dec 2014
Search Stocks